Pharma Pulse 7/23/24: The Data That Powers AI is Disappearing Fast, Stay Aware of Common High-Alert Medications & more

Study Finds Oral Corticosteroid Use Over 90 Days Slightly Increases Adverse Event Risk in Adults with Atopic Dermatitis

Study finds a potential risk of adverse events associated with long-term use of oral corticosteroids in patients with exacerbations of atopic dermatitis.

Stay Aware of Common High-Alert Medications

Pharmacists can prevent medication errors through knowledge, communication, and education.

The Data That Powers A.I. Is Disappearing Fast

New research from the Data Provenance Initiative has found a dramatic drop in content made available to the collections used to build artificial intelligence.

Where to Invest in Health Trends

Five experts point to investment opportunities related to advancements being made in physical and mental health.

Suzanne Shelley (she/her) on LinkedIn

I'm proud to share my latest bylined article (a bit late), which appears in the June 2024 issue of Pharmaceutical Commerce Magazine...

Entitled "Combining RWE and AI to Bend the Adherence Curve," my article explores how marrying increasingly diversified sources or real-world evidence with rapidly expanding AI options (including natural language processing, machine learning techniques, generative AI and others), creates new opportunities for pharma/life sciences stakeholders to tailor their support programs and interventions — to help both patients and prescribers to overcome access, affordability and adherence challenges that hinder clinical and financial outcomes for all.

As always, I'm grateful for the thoughtful input from my sources atFortrea, EVERSANA, IQVIA, Syneos Health, AssistRx and AllazoHealth.

Check it out if you're so inclined:

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs